Inc Arqule

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.

Founded in 2003, Biodel is a pharmaceutical company that develops novel formulations for therapeutic care solutions. It offers medicines for the treatment of various endocrine disorders, including diabetes and osteoporosis. The company uses VIAdel technology, which enables delivery of endocrine therapeutics into blood through various routes of administration. Biodel also offers VIAject, which is an injectable human insulin product. It provides VIAtab, which is an oral human insulin product. The company offers VIAmass and VIAcal that formulates parathyroid hormone and salmon calcitonin for the treatment of osteoporosis. Additionally, Biodel provides a variety of clinical trial services and organizes various community events.

KemLab Inc., located in Woburn, Massachusetts, specializes in the production of high-purity SU-8 epoxy photoresists tailored for the microelectronics industry. Their SQ Series offers enhanced cleanliness and consistent lithographic performance, making it suitable for a range of applications including MEMS microfluidics and permanent microelectronic devices. Dedicated to superior quality, KemLab prides itself on utilizing advanced manufacturing processes to create competitive photoresist materials that outperform legacy options. Their comprehensive range of products includes options for both thick and thin films, ensuring compatibility with established SU-8 lithographic processes. Generated from the website